Health Care Related Foundation & Initiatives

AABB
http://www.aabb.org/Pages/Homepage.aspx
Mission: AABB advances the practice and standards of transfusion medicine and cellular therapies to optimize patient and donor care and safety.

National Cervical Cancer Coalition
http://www.nccc-online.org/index.html
Mission: First founded in 1996, The National Cervical Cancer Coalition (NCCC) is a growing coalition of people battling cervical cancer and HPV related issues.

National Birth Defects Prevention Network (NBDPN)
http://www.nbdpn.org/current/resources/bdpm2009.html
Mission: The National Birth Defects Prevention Network (NBDPN) is a group of individuals involved in birth defects surveillance, research, and prevention.  It was created to establish and maintain a national network of state and population-based programs for birth defects surveillance and research.  The Network assesses the impact of birth defects upon children, families, and health care; identifies factors that can be used to develop primary prevention strategies; and assists families and their providers in secondary disabilities prevention.

Prevent Blindness America
http://preventblindness.org/news/observe.html
Mission: Founded in 1908, Prevent Blindness America is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness America touches the lives of millions of people each year.

National Cancer Institute
http://prevention.cancer.gov/
The Division of Cancer Prevention’s mission is to plan, direct, implement, and monitor cancer research and training that is focused on early detection, cancer risk, chemoprevention, and supportive care.

DCP projects address the need to identify where a person is in the process of carcinogenesis, and to determine ways to actively intervene to stop it from becoming invasive cancer. Varied approaches are supported, from pre-clinical discovery and development of biomarkers and chemoprevention agents, including pharmaceuticals and micronutrients, to Phase III clinical testing. Programs are harmonized with other NCI divisions, NIH institutes, and federal and state agencies.